Abstract
Ovarian cancer is the gynecologic malignancy with the highest number of deaths in the United States. Previous studies had found a decreased incidence of female gynecological malignancies after liver transplantation. In order to estimate the incidence of ovarian carcinoma after liver transplantation, we evaluated 1708 consecutive liver transplant recipients from 1984 to 2001. Of them, 770 (43%) were female. Routine follow-ups were performed at 1, 2, 5, and 10 years after transplantation. There were two cases of ovarian carcinoma. Both occurred in recipients with a previous history of breast cancer. Based on these data, we conclude that the incidence of ovarian cancer is 1:385 among all female liver transplant recipients, and 1:6.5 among those with a history of pretransplant breast cancer. We recommend that regular check-ups should be undertaken, especially in the population at highest risk.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Penn I: Posttransplantation de novo malignancies. In Transplantation of the Liver. RW Busuttil, GB Klintmalm (eds). Philadelphia, WB Saunders Co. 1996, pp 731-738
Penn I: Neoplastic complications of organ transplantation. In Transplantation. LC Ginns, AB Cosimi, PJ Morris (eds). Malden, Massachusetts, Blackwell Science. 1999, pp 770-786
Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, Zak M, Rakela J, Irish W, Fung JJ: Comparative incidence of de novo nonlymphoid malignancies after liver Transplantation under tacrolimus suing surveillance epidemiologic end result data. Transplantation 66:1193-1200, 1998
Ozols RF, Schwartz PE, Eifel PA: Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In Cancer. Principles and Practice of Oncology. 6th ed. V DeVita Jr, S Hellman, S Rosenberg (eds). Philadelphia, Lippincott Williams & Wilkins. 2001, pp 1597-1632
Young RC: Gynecologic malignancies. In Harrison's Principles of Internal Medicine, 15th ed. E Braunwald, AS Fauci, DL Kasper, SL Hauser, DL Longo, JL Jameson (eds). New York, McGraw-Hill. 2001, pp 620-625
Kuo DY, Jones JG, Runowicz CD: Diseases of the ovary and fallopian tubes. In Danforth's Obstetrics & Gynecology, 8th ed. JR Scott, PJ DiSaia, CB Hammond, WN Spellacy (eds). Philadelphia, Lippincott Williams & Wilkins. 1999, pp 865-908
Bennington JL, Ferguson BR, Haber SL: Incidence and relative frequency of benign and malignant neoplasms. Obstet Gynecol 32:627-632, 1968
Harlap S: The Epidemiology of ovarian cancer. In Cancer of the Ovary. M Markman, WJ Hoskins (eds). New York, Raven Press. 1993, pp 79-93
Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 16,359:572-577, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Molmenti, E.P., Molmenti, H., Weinstein, J. et al. Syndromic Incidence of Ovarian Carcinoma After Liver Transplantation, with Special Reference to Anteceding Breast Cancer. Dig Dis Sci 48, 187–189 (2003). https://doi.org/10.1023/A:1021715305407
Issue Date:
DOI: https://doi.org/10.1023/A:1021715305407